Negative Pressure Ventilation in Paediatric Patients During Weaning

Status Recruiting

Clinical Trial Summary

Negative pressure ventilation (NPV) represent a unique form of noninvasive ventilation using negative pressure by specialized cuirass, that evolve negative pressure on the front size of chest and partially abdomen and facilitate the spontaneous breathing. The benefit of NPV beside noninvasive application, is the supreme tolerance of the patient (compared to other forms of noninvasive ventilation - mask, helmet), without the negative impact on enteral feeding tolerance and with the possibility of active physiotherapy. NPV could be even combined with oxygentherapy or noninvasive positive pressure ventilation. NPV in paediatric patients after extubation could be associated with reduced incidence of weaning failure.

Clinical Trial Description

After ethics committee approval and informed consent from legal guardians and fulfilling inclusion criteria, critically ill paediatric patients scheduled for weaning will be randomized (in 1:1 allocation) to NPV (interventional group) or standard approach (without NPV) after extubation. NPV in paediatric patients after extubation could be associated with reduced incidence of weaning failure. The initial setting on NPV will be: negative pressure set to -10cmH2O and will proceed for minimal time of 60 minutes after extubation (will proceed longer in case of good tolerance). In case of hypoxaemia, additional oxygentherapy will be administered according to the patients condition Primary outcome will be defined as postextubation failure incidence at 60 minutes after extubation (defined as need of noninvasive positive pressure ventilation, intubation, or high-flow oxygen therapy) and the overall incidence of weaning failure during initial 24 hour after extubation. The secondary outcome will be the dynamics of blood gases (arterial or capillary blood sample) during initial 60 minutes after extubation (1. extubation, 2. 60 minutes after extubation) and the need of and amount of artificial oxygentherapy (litres of oxygen per minute, pulse oximetry). Another outcome will be the overall cuirass tolerance after 60 minutes and after 24 hours defined by incidence of skin lesions. ;

Study Design

Related Conditions & MeSH terms

Weaning Failure

Clinical Trial Details

NCT number	NCT05035290
Study type	Interventional
Source	Brno University Hospital
Contact	Jozef Klucka, assoc.prof.MD., Ph.D.
Phone	532234696
Email	klucka.jozef@fnbrno.cz
Status	Recruiting
Phase	N/A
Start date	February 1, 2022
Completion date	December 31, 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05539599` - Comprehensive Ultrasound Evaluation as a Predictor of Weaning
Completed	`NCT02845076` - Weaning From Noninvasive Ventilation	N/A
Completed	`NCT01915563` - Rest After Spontaneous Breathing Trial for Prevention of Post-extubation Failure	N/A
Recruiting	`NCT01721434` - Effects of Levosimendan on Diaphragm Function in Mechanically Ventilated Patients	Phase 2/Phase 3
Completed	`NCT01928277` - Weaning From Mechanical Ventilation: Spontaneous Breathing Trial and the Assessment of Work of Breathing	N/A
Recruiting	`NCT05632822` - Value of Diaphragm Function Predicting Weaning From Mechanical Ventilation
Recruiting	`NCT03240263` - Inspiratory Muscle Training in Difficult to Wean Patients	N/A
Completed	`NCT06332768` - NIV Versus HFO Versus Standard Therapy Immediately After Weaning From Mechanical Ventilation in ARDS Patients	N/A
Completed	`NCT01867853` - Volume Responsiveness Before SBT Predicts the Outcome of Mechanical Ventilation Weaning in Critically Ill Patients	N/A
Recruiting	`NCT06040138` - Monitoring of Breathing Effort Through Pressure Time Product Measurement Using Airway Occlusion Pressure
Completed	`NCT06224010` - Respiratory Drive and Inspiratory Effort in COVID-19 Associated ARDS
Completed	`NCT03129217` - The Validity of Maximal Diaphragm Thickening Fraction to Measure Diaphragm Function in Mechanically Ventilated Patients
Completed	`NCT05550220` - A Modified Cuff Leak Test and Reintubation in Mechanically Ventilated Patients	N/A
Not yet recruiting	`NCT05431036` - Evaluation of a Combined Model in Predicting Weaning Outcome in Critically Ill Patients.
Recruiting	`NCT05906888` - Weaning With Tracheostomy - an Observational Study on Patient-centered Outcomes
Recruiting	`NCT05944588` - Predictive Value of Chest Ultrasound Observation on Extubation Failure
Not yet recruiting	`NCT05802745` - P0.1 and Extubation Failure in Critically Ill Patients
Recruiting	`NCT03894189` - The Effect of Doxapram Versus Theophylline on Diaphragmatic Function	N/A
Completed	`NCT01877850` - Utility of a Weaning Protocol in ICU	N/A
Completed	`NCT03580720` - Electromyography for Diaphragm Effort	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Negative Pressure Ventilation in Paediatric Patients During Weaning — NEGWEAN

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms